| 摘要 |
Disclosed are a medicament for treating or preventing diseases with myocardial necrosis, which contains, as an active ingredient, a periostin variant (ΔbΔe) polypeptide or a modified form thereof or a polynucleotide encoding the same; and a diagnostic agent for diseases with myocardial necrosis containing a DNA encoding a periostin variant (ΔbΔe) polypeptide or a partial fragment thereof or an antibody which specifically recognizes a periostin variant (ΔbΔe) polypeptide.
|
